Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

This study has been completed.
Information provided by:
Foundation for Liver Research Identifier:
First received: June 14, 2005
Last updated: June 18, 2010
Last verified: June 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)